CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
RADx CHCs testing intervention strategy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04802187
NCT04802187N/ACompleted
CompareCT.gov

Implementation of COVID-19 Testing Strategies in Community Health Centers

Massachusetts General Hospital·interventional·Posted Mar 17, 2021·Updated Nov 8, 2023

In Brief

A clinical study evaluating RADx CHCs testing intervention strategy and Usual care control for Covid19. Completed, enrolled 6 participants across 2 sites.

Detailed Summary

This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in MA, through 6 community health center (CHC)-community partnerships. A base strategy will be implemented at all sites. A tailored strategy unique to local populations will be added and tested in a stepped wedge design.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesUnited States
CollaboratorsDana-Farber Cancer Institute, Harvard School of Public Health (HSPH), Massachusetts League of Community Health Centers, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMar 17, 2021
Enrollment StartDec 1, 2020
Primary CompletionJul 15, 2022
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 5.3 years ago

Interventions

RADx CHCs testing intervention strategyother

The study team will support partner CHCs to implement workflows with some combination of dedicated testing staff, off-site testing, outreach/communications to priority populations, and linkage with local contact tracing systems. Implementation support will take the form of practice facilitation, rapid cycle testing (by supporting CHCs to review their internal data to assess the impact of workflow changes), and expert consultation from the research team on testing technology and testing location design.

Usual care controlother

CHCs implement testing strategies in accordance with their usual supports.